Log in | Join Free | china | japan | germany

Tofacitinib Impurity

Request For Quotation
Tofacitinib Impurity Suppliers list
Company Name: ANHUI WITOP BIOTECH CO., LTD
Tel: +8615255079626
Email: eric@witopchemical.com
Products Intro: Product Name:Tofacitinib Impurity 29
CAS:90953-01-8
Company Name: Jinan blalong chemical co. LTD  
Tel: 2710913286@.com
Email: 1513643261@qq.com
Products Intro: Product Name:TofacitinibImpurity29
CAS:90953-01-8
Purity:99% HPLC Package:50G;10G;1G;500MG;100MG
Company Name: Shenzhen ruikai de biotechnology co., ltd.  
Tel: 0755-61348847 17820674378
Email: 2682116078@qq.com
Products Intro: Product Name:Tofacitinib Impurity 29
CAS:90953-01-8
Purity:98%HPLC Package:10mg;25mg;50mg;100mg
Company Name: Meng Cheng Technology (Shanghai) Co., LTD  
Tel: 400-820-6829
Email: sales@mitachieve.com
Products Intro: Product Name:Tofacitinib Impurity
CAS:90953-01-8
Purity:＞99% Package:100mg
Company Name: SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD  
Tel: 0755-0755-0755-83725350 13380397412
Email: 3001280422@qq.com
Products Intro: Product Name:Tofacitinib Impurity JT2-I
CAS:90953-01-8
Purity:99% HPLC Package:10mg;25mg;50mg;100mg
Tofacitinib Impurity Basic information
Product Name:Tofacitinib Impurity
Synonyms:Tofacitinib Impurity JT2-I;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N,N-dimethyl-
CAS:90953-01-8
MF:C8H10N4
MW:162.19
EINECS:
Product Categories:
Mol File:90953-01-8.mol
Tofacitinib Impurity Structure
Tofacitinib Impurity Chemical Properties
Boiling point 300.6±45.0 °C(Predicted)
density 1.27±0.1 g/cm3(Predicted)
pka13.34±0.20(Predicted)
Safety Information
MSDS Information
Tofacitinib Impurity Usage And Synthesis
Tofacitinib Impurity Preparation Products And Raw materials
Tag:Tofacitinib Impurity(90953-01-8) Related Product Information
(3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity 36 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE Tofacitinib Related Compound Tofacitinib Impurity 45 Tofacitinib Impurity 2